🔎 Trials Near Me

Home › Smoking and Youth › NCT06693700

A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home

RecruitingHealthy volunteers welcome

Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Adult (aged \>18 years) MSK patients as per the EHR
* Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
* Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
* Must be English-speaking in the EHR
* Must be reachable by phone as per self-report
* Must have Wi-Fi available at home as per self-report

Exclusion Criteria:

* Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report

About the study

The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.

What is being tested

Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 10 · Started: Nov 14, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06693700

Locations in the U.S.

New JerseyMemorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge
Memorial Sloan Kettering Monmouth (Consent only), Middletown
Memorial Sloan Kettering Bergen (Consent only), Montvale
New YorkMemorial Sloan Kettering Suffolk-Commack (Consent only), Commack
Memorial Sloan Kettering Westchester (Consent only), Harrison
City College of New York (Data Collection AND Data Analysis), New York (Not yet recruiting)
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Memorial Sloan Kettering Nassau (Consent only), Uniondale

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.